Varilrix Vaccination

The target recipients for vaccination at Diag are adults.

Contraindications

• Postpone vaccination with Varilrix vaccine for people with acute high fever.
• The injection is contraindicated for people with severe humoral or cellular immunodeficiency such as:
  • Primary immunodeficiency or lymphocyte count less than 1,200/mm3.
  • People with cellular immunity deficiencies such as diphtheria, lymphoma, hematopoietic disorders, and HIV infection.
  • Patients on immunosuppressive treatment (including the use of high doses of corticosteroids).
• Varilrix injection is contraindicated for people who are hypersensitive to neomycin or any other ingredient in the vaccine.
• Do not vaccinate people who show signs of hypersensitivity after a previous dose of chickenpox vaccine. Not for use by pregnant women, it is best to complete the vaccination regimen 3 months before pregnancy.

Varilrix (Belgium) is a live-attenuated varicella vaccine that contains the Oka-strain of the attenuated varicella-zoster virus.

• Dose 1: Initial Dose.
• Dose 2: 4 weeks after 1 dose.

To get vaccinated against varicella, vaccinated people should note that within the last 1 month, they have not received live attenuated vaccines, including measles, mumps, rubella, polio (oral), smallpox, chickenpox, BCG, typhoid (oral), yellow fever, rotavirus, and influenza.